Spencer Chapman, Michael https://orcid.org/0000-0002-5320-8193
Wilk, C. Matthias https://orcid.org/0000-0001-5429-7143
Boettcher, Steffen https://orcid.org/0000-0001-9937-0957
Mitchell, Emily
Dawson, Kevin
Williams, Nicholas https://orcid.org/0000-0003-3989-9167
Müller, Jan
Kovtonyuk, Larisa
Jung, Hyunchul
Caiado, Francisco https://orcid.org/0000-0003-4096-4448
Roberts, Kirsty
O’Neill, Laura
Kent, David G. https://orcid.org/0000-0001-7871-8811
Green, Anthony R.
Nangalia, Jyoti https://orcid.org/0000-0001-7122-4608
Manz, Markus G. https://orcid.org/0000-0002-4676-7931
Campbell, Peter J. https://orcid.org/0000-0002-3921-0510
Article History
Received: 27 April 2023
Accepted: 27 September 2024
First Online: 30 October 2024
Competing interests
: P.J.C. is a co-founder, stock holder and consultant for Quotient Therapeutics.